Quantitative determination of IgM antibodies reduces the pitfalls in the serodiagnosis of tick-borne encephalitis

Journal of Clinical Virology

Volumn 54, Issue 2, 2012, Pages 115-120

  Stiasny, K ^a   Aberle, J H ^a   Chmelik, V ^b   Karrer, U ^c   Holzmann, H ^a   Heinz, F X ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hospital Ceske Budejovice as   (Czech Republic)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

IgM antibody response; Serodiagnosis; Tick borne encephalitis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; TICK BORNE ENCEPHALITIS VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CROSS REACTION; DENGUE; FEMALE; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SERODIAGNOSIS; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; WEST NILE FEVER;

ADULT; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; COHORT STUDIES; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; MIDDLE AGED; SEROLOGIC TESTS; TIME FACTORS; VIROLOGY;

EID: 84860319107     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.02.016     Document Type: Article

References (37)

1. Simmonds P., Becher P., Collett M.S., Gould E.A., Heinz F.X., Meyers G., et al. Family Flaviviridae. Virus taxonomy IXth report of the international committee on taxonomy of viruses 2011, Elsevier Academic Press, San Diego. A.M.Q. King, E. Lefkowitz, M.J. Adams, E.B. Carstens (Eds.).
2. WHO Vaccines against tick-borne encephalitis: WHO position paper. Wkly Epidemiol Rec 2011, 86:241-256.
3. Ruzek D., Dobler G., Donoso Mantke O. Tick-borne encephalitis: pathogenesis and clinical implications. Travel Med Infect Dis 2010, 8:223-232.
4. Charrel R.N., Attoui H., Butenko A.M., Clegg J.C., Deubel V., Frolova T.V., et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect 2004, 10:1040-1055.
5. Lindquist L., Vapalahti O. Tick-borne encephalitis. Lancet 2008, 371:1861-1871.
6. Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine 2003, 21(Suppl 1):S36-S40.
7. Saksida A., Duh D., Lotric-Furlan S., Strle F., Petrovec M., Avsic-Zupanc T. The importance of tick-borne encephalitis virus RNA detection for early differential diagnosis of tick-borne encephalitis. J Clin Virol 2005, 33:331-335.
8. Dorrbecker B., Dobler G., Spiegel M., Hufert F.T. Tick-borne encephalitis virus and the immune response of the mammalian host. Travel Med Infect Dis 2010, 8:213-222.
9. Kunze U. TBE-awareness and protection: the impact of epidemiology, changing lifestyle, and environmental factors. Wien Med Wochenschr 2010, 160:252-255.
10. Gunther G., Haglund M., Lindquist L., Skoldenberg B., Forsgren M. Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome. Clin Diagn Virol 1997, 8:17-29.
11. Hofmann H., Kunz C., Heinz F.X., Dippe H. Detectability of IgM antibodies against TBE virus after natural infection and after vaccination. Infection 1983, 11:164-166.
12. Zeller H.G., Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 2004, 23:147-156.
13. Blitvich B.J. Transmission dynamics and changing epidemiology of West Nile virus. Anim Health Res Rev 2008, 9:71-86.
14. Hofmann H., Heinz F.X., Dippe H. ELISA for IgM and IgG antibodies against tick-borne encephalitis virus: quantification and standardization of results. Zentralbl Bakteriol Mikrobiol Hyg A 1983, 255:448-455.
15. Stiasny K., Holzmann H., Heinz F.X. Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs. Vaccine 2009, 27:7021-7026.
16. Loew-Baselli A., Poellabauer E.M., Pavlova B.G., Fritsch S., Firth C., Petermann R., et al. Prevention of tick-borne encephalitis by FSME-IMMUN((R)) vaccines: review of a clinical development programme. Vaccine 2011, 29:7307-7319.
17. Aberle J.H., Stiasny K., Kundi M., Heinz F.X. Mechanistic insights into the impairment of memory B cells and antibody production in the elderly. Age (Dordr) 2012, [Epub ahead of print]. 10.1007/s11357-011-9371-9.
18. Jilkova E., Vejvalkova P., Stiborova I., Skorkovsky J., Kral V. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly-results from an observational study. Expert Opin Biol Ther 2009, 9:797-803.
19. Weinberger B., Keller M., Fischer K.H., Stiasny K., Neuner C., Heinz F.X., et al. Decreased antibody titers and booster responses in tick-borne encephalitis vaccines aged 50-90 years. Vaccine 2010, 28:3511-3515.
20. Roehrig J.T., Nash D., Maldin B., Labowitz A., Martin D.A., Lanciotti R.S., et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003, 9:376-379.
21. Busch M.P., Kleinman S.H., Tobler L.H., Kamel H.T., Norris P.J., Walsh I., et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008, 198:984-993.
22. Monath T.P. Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans. Am J Epidemiol 1971, 93:122-129.
23. Edelman R., Schneider R.J., Vejjajiva A., Pornpibul R., Voodhikul P. Persistence of virus-specific IgM and clinical recovery after Japanese encephalitis. Am J Trop Med Hyg 1976, 25:733-738.
24. Papa A., Danis K., Athanasiadou A., Delianidou M., Panagiotopoulos T. Persistence of West Nile virus immunoglobulin M antibodies, Greece. J Med Virol 2011, 83:1857-1860.
25. Lemon S.M. Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem 1997, 43:1494-1499.
26. Cho H.W., Howard C.R. Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax). Vaccine 1999, 17:2569-2575.
27. Heinz F.X., Holzmann H., Essl A., Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 2007, 25:7559-7567.
28. Andersson C.R., Vene S., Insulander M., Lindquist L., Lundkvist A., Gunther G. Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine 2010, 28:2827-2831.
29. Papa A., Karabaxoglou D., Kansouzidou A. Acute West Nile virus neuroinvasive infections: cross-reactivity with dengue virus and tick-borne encephalitis virus. J Med Virol 2011, 83:1861-1865.
30. Westaway E.G. Greater specificity of 19S than 7S antibodies on haemagglutination-inhibition tests with closely related group B arboviruses. Nature 1968, 219:78-79.
31. Koraka P., Zeller H., Niedrig M., Osterhaus A.D., Groen J. Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect 2002, 4:1209-1215.
32. Scott R.M., McCown J.M., Russell P.K. Human immunoglobulin specificity after group B arbovirus infections. Infect Immun 1972, 6:277-281.
33. A-Nuegoonpipat A., Panthuyosri N., Anantapreecha S., Chanama S., Sa-Ngasang A., Sawanpanyalert P., et al. Cross-reactive IgM responses in patients with dengue or Japanese encephalitis. J Clin Virol 2008, 42:75-77.
34. Monath T.P., Nystrom R.R., Bailey R.E., Calisher C.H., Muth D.J., Immunoglobulin M. antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis. J Clin Microbiol 1984, 20:784-790.
35. Makino Y., Tadano M., Saito M., Maneekarn N., Sittisombut N., Sirisanthana V., et al. Studies on serological cross-reaction in sequential flavivirus infections. Microbiol Immunol 1994, 38:951-955.
36. Holzmann H., Kundi M., Stiasny K., Clement J., McKenna P., Kunz C., et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol 1996, 48:102-107.
37. Stiasny K., Kiermayr S., Holzmann H., Heinz F.X. Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol 2006, 80:9557-9568.